These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


177 related items for PubMed ID: 7274182

  • 21. [The cancerous action of arsenic and nickel (author's transl)].
    Konetzke GW.
    Arch Geschwulstforsch; 1974; 44(1):16-22. PubMed ID: 4447437
    [No Abstract] [Full Text] [Related]

  • 22. Asbestos as a cofactor in carcinogenesis among nickel-processing workers.
    Langer AM, Rohl AN, Selikoff IJ, Harlow GE, Prinz M.
    Science; 1980 Jul 18; 209(4454):420-2. PubMed ID: 7384817
    [Abstract] [Full Text] [Related]

  • 23. Nickel carcinogenesis.
    Kasprzak KS, Sunderman FW, Salnikow K.
    Mutat Res; 2003 Dec 10; 533(1-2):67-97. PubMed ID: 14643413
    [Abstract] [Full Text] [Related]

  • 24. Mechanisms of dissolution of nickel subsulfide in rat serum.
    Kasprzak KS, Sunderman FW.
    Res Commun Chem Pathol Pharmacol; 1977 Jan 10; 16(1):95-108. PubMed ID: 841185
    [Abstract] [Full Text] [Related]

  • 25. Genotoxicity of 1,3-butadiene and its epoxy intermediates.
    Walker VE, Walker DM, Meng Q, McDonald JD, Scott BR, Seilkop SK, Claffey DJ, Upton PB, Powley MW, Swenberg JA, Henderson RF, Health Review Committee.
    Res Rep Health Eff Inst; 2009 Aug 10; (144):3-79. PubMed ID: 20017413
    [Abstract] [Full Text] [Related]

  • 26. Dose-response and time-response study of erythrocytosis in rats after intrarenal injection of nickel subsulfide.
    Morse EE, Lee TY, Reiss RF, Sunderman FW.
    Ann Clin Lab Sci; 1977 Aug 10; 7(1):17-24. PubMed ID: 836000
    [Abstract] [Full Text] [Related]

  • 27. Metal interactions in carcinogenesis: enhancement, inhibition.
    Nordberg GF, Andersen O.
    Environ Health Perspect; 1981 Aug 10; 40():65-81. PubMed ID: 7023935
    [Abstract] [Full Text] [Related]

  • 28. Phagocytosis of particulate nickel compounds by rat peritoneal macrophages in vitro.
    Kuehn K, Fraser CB, Sunderman FW.
    Carcinogenesis; 1982 Aug 10; 3(3):321-6. PubMed ID: 7083473
    [Abstract] [Full Text] [Related]

  • 29. Unrecognized risks of nickel-related respiratory cancer among Canadian electrolysis workers.
    Grimsrud TK, Andersen A.
    Scand J Work Environ Health; 2012 Nov 10; 38(6):503-15. PubMed ID: 22258056
    [Abstract] [Full Text] [Related]

  • 30. Carcinogenicity of occupational nickel exposures: an evaluation of the epidemiological evidence.
    Grandjean P, Andersen O, Nielsen GD.
    Am J Ind Med; 1988 Nov 10; 13(2):193-209. PubMed ID: 3281454
    [Abstract] [Full Text] [Related]

  • 31. Induction of soft tissue tumours in F344 rats by subcutaneous, intramuscular, intra-articular, and retroperitoneal injection of nickel sulphide (Ni3S2).
    Shibata M, Izumi K, Sano N, Akagi A, Otsuka H.
    J Pathol; 1989 Mar 10; 157(3):263-74. PubMed ID: 2538612
    [Abstract] [Full Text] [Related]

  • 32. Inducation of chromosomal aberrations in cultured mammalian cells by nickel compounds.
    Nishimura M, Umeda M.
    Mutat Res; 1979 Dec 10; 68(4):337-49. PubMed ID: 522882
    [Abstract] [Full Text] [Related]

  • 33. Comparative carcinogenic effects of nickel subsulfide, nickel oxide, or nickel sulfate hexahydrate chronic exposures in the lung.
    Dunnick JK, Elwell MR, Radovsky AE, Benson JM, Hahn FF, Nikula KJ, Barr EB, Hobbs CH.
    Cancer Res; 1995 Nov 15; 55(22):5251-6. PubMed ID: 7585584
    [Abstract] [Full Text] [Related]

  • 34. Chromosomal abnormalities and gene amplification in renal cancers induced in rats by nickel subsulfide.
    Sunderman FW, Hopfer SM, Nichols WW, Selden JR, Allen HL, Anderson CA, Hill R, Bradt C, Williams CJ.
    Ann Clin Lab Sci; 1990 Nov 15; 20(1):60-72. PubMed ID: 2310171
    [Abstract] [Full Text] [Related]

  • 35. Fate of nickel subsulfide during carcinogenesis studied by autoradiography and X-ray powder diffraction.
    Oskarsson A, Andersson Y, Tjälve H.
    Cancer Res; 1979 Oct 15; 39(10):4175-82. PubMed ID: 476653
    [Abstract] [Full Text] [Related]

  • 36. Distribution of various nickel compounds in rat organs after oral administration.
    Ishimatsu S, Kawamoto T, Matsuno K, Kodama Y.
    Biol Trace Elem Res; 1995 Jul 15; 49(1):43-52. PubMed ID: 7577320
    [Abstract] [Full Text] [Related]

  • 37. Carcinogenicity of nickel(II)hydroxides and nickel(II)sulfate in Wistar rats and its relation to the in vitro dissolution rates.
    Kasprzak KS, Gabryel P, Jarczewska K.
    Carcinogenesis; 1983 Jul 15; 4(3):275-9. PubMed ID: 6831634
    [Abstract] [Full Text] [Related]

  • 38. Increased serum erythropoietin activity in rats following intrarenal injection of nickel subsulfide.
    Hopfer SM, Sunderman FW, Fredrickson TN, Morse EE.
    Res Commun Chem Pathol Pharmacol; 1979 Jan 15; 23(1):155-70. PubMed ID: 441509
    [Abstract] [Full Text] [Related]

  • 39. Negative test for transplacental carcinogenicity of nickel subsulfide in Fischer rats.
    Sunderman FW, McCully KS, Rinehimer LA.
    Res Commun Chem Pathol Pharmacol; 1981 Mar 15; 31(3):545-54. PubMed ID: 7255885
    [Abstract] [Full Text] [Related]

  • 40. Nickel in welding fumes--a cancer hazard to welders? A review of epidemiological studies on cancer in welders.
    Langård S, Stern RM.
    IARC Sci Publ; 1984 Mar 15; (53):95-103. PubMed ID: 6398291
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.